Dr. Altay Aliyev

Internal Medicine and Medical Oncology Specialist

Dr. Altay Aliyev

Internal Medicine and Medical Oncology Specialist

Chief of Medical Oncology Departament

Education and Work Experience:

2004 -2010 Istanbul University, Istanbul Faculty of Medicine

2011-2015 Istanbul University, Istanbul Faculty of Medicine, Internal Medicine Residency,

2013-2014  Cleveland Clinic Endocrinology Research Fellow

2016-2019  Bezmi Alem University, Faculty of Medicine, Medical Oncology Fellowship

Internal Medicine Speciality Dissertation: Prognostic Value of Absolute Monocyte Count in Mantle Cell Lymphoma Patients.

Medical Oncology Fellowship Dissertation: The Effect of Adjuvant Chemotherapy on Lipid Profile and Anthropometric Parameters in Breast and Colon Cancer Patients.

Specialty in Diseases & Conditions:

  1. Cancer Prevention, screening and diagnosis.
  2. Palliative and Supportive care.
  3. Cytotoxic chemotherapy.
  4. Hormone therapy.
  5. Targeted treatment.

Publications on Sci- Expended Journals:

  1. Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggresiveness in Patients With Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M,  et al. Endocr Pract.2015 Jul;21(7):777-81. doi: 10.4158/EP14425.OR. Epub 2015 Mar 18.
  2. The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.
    Aliyev A, Soundararajan S, Bucak E et al. Surgery. 2015 Oct;158(4):1089-93; discussion 1093-4. doi: 10.1016/j.surg.2015.06.023. Epub 2015 Jul 23.
  3. Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9.
  4. Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat.2018;41(9):545-549. doi: 10.1159/000490120. Epub 2018 Aug 20.
  5. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan;83(1):131-143. doi: 10.1007/s00280-018-3712-7. Epub 2018 Oct 30.
  6. Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: S0147-0272(19)30060-1. doi: 10.1016/j.currproblcancer.2019.06.009.
  7. Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal.

Oral Presentations:

  1. Treatment Modalities for Stage IV Diseases in Colorectal Cancer 6th Meeting 6-11 May 2018 Istanbul. Evaluation bone Metastases risk factors in colorectal Cancer Patients. Kolorektal kanserli hastalarda kemik metastazı risk faktörlerinin değerlendirilmesi. Tarık Demir, Altay Aliyev.
  2. Treatment Modalities for Stage IV Diseases in Colorectal Cancer 6th Meeting 6-11 May 2018 Istanbul. Rare brain metastasis of colorectal cancers: risk factors, prognosis and clinical features. Altay Aliyev, Tarık Demir,et al.
  1. 8 th International Gastrointestinal Cancer Conference 7-9 December Istanbul. Rare brain metastasis of colorectal cancers: risk factors, prognosis and clinical features. Tarık Demir, Altay Aliyev.
  1. Actual Devoloping in Cancer. Lung Cancer. Diyarbakır 2018. Clinical Features of Malignant Patients with Pulmnary Embolism. Altay Aliyev.
  1. 23rd National Cancer Congress. Antalya 2019. Pathological Complete Response Related Factors in Breast Cancer Patients Receiving Neoadjuvant Chemotheraphy. Ezgi Çoban, Mehmet Beşiroğlu, Altay Aliyev, et al.
  1. 23rd National Cancer Congress. Antalya 2019. Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma? Tarık Demir, Murat Araz, Altay Aliyev, et al.
  1. 2nd Eskishehir Oncology Meeting. April 2019. The Effect of Adjuvant Chemotherapy on Lipid Profile and Anthropometric Parameters in Breast and Colon Cancer Patients. Altay Aliyev, Mehmet Besiroglu.
  2. KLIMIK 2016 30. Yıl Kurultayı. Mart 2016 Antalya. Colistin-Resistant Klebsiella pneumoniae-Induced Pylephlebitis Caused by Continuous Bacteremia: A Case Treated with Interventional Radiological Method.. Vasif Aliyev, Altay Aliyev, et al.
  3. Health Sciences University Internal Medicine Congress. 26-30 June 2018 Istanbul. Prognostic Value of Absolute Monocyte Count in Mantle Cell Lymphoma Patients. Altay Aliyev, Tarık Demir, Meliha Nalcacı.
  4. 2 nd International Congress on Oncological Sciences.20-23 September Antalya. The C-Reactive Protein/ Albumin Ratio, A Novel Inflammation- Based Prognostic Score, Predicts Outcomes in Patients With Biliary Tract Cancer. Tarık Demir, Altay Aliyev, et al.
  5. 35th National Congress of Nephrology, Hypertension, Dialysis and Transplantation. October 2018 Antalya. Long-Term Effect of Chemotherapy on Renal Function in Patients with Cancer. Elgun Haziyev, Meltem Gursu, Altay Aliyev, et al.

International Phase II-III studies that I participated as a researcher:

  1. Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma. Protokol Code:WO30070
  2. Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors.
  3. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU).
  4. A Study of FPA144 Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer (FIGHT).
  5. ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.
  6. Study of REGN2810 (Anti-PD-1) in Advanced NSCLC Patients With.

Posters:

  1. 22nd National Cancer Congress. 19-23 April 2017 Antalya. Clinical Features and Prognostic Factors of Hepatocellular Cancer Patients with Follow-up at Eskişehir Osmangazi University Servet Bilir Oncology Center. Altay Aliyev, Pınar Dal, et al.
  2. 22nd National Cancer Congress. 19-23 April 2017 Antalya. Clinical and Pathological Parameters Affecting Surgical Boundary Proximity / Positivity in Operated Breast Cancer Patients. Nuray Bali, Bülent Yıldız,Altay Aliyev, et al.
  3. ASCO 2019 Annual Meeting. Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer. Ulas Isık, Osman Kostek, Altay Aliyev et al. J Clin Oncol 37, 2019 (suppl; abstr e16075).

Courses and Congresses:

  1. Hedef Kanser 2017 6-8 Aprel Kipr.
  2. Post graduated courses/ Basic Education of Clinical Trials/19-20 November 2016 İzmir
  3. Post graduated courses / İnteraktif Toraks Onkoloji Kursu/16-17 Sentyabr 2017 İstanbul
  4. Post graduated courses / Interactive Breast Cancer Course/23-24 Dekabr 2017 İstanbul
  5. Post graduated courses / Gastrointestinal System Malignancy Course/ 10-11 Fevral 2018 Ankara
  6. Post graduated courses / Hematologic Malignancy Course/ 5-6 May 2018 İstanbul
  7. ASCO 2018/1-5 İyun 2018 Chicago, USA
  8. Best of ASCO 2018/23 June İstanbul
  9. Euroasian Uro-Oncology Congress/ 28.6-1.7.2018 Tiflis
  10. Turkish Medical Oncology Congress / 21-25 March 2018 Antalya
  11. Post graduated courses / Gynecological Malignancy Course /8-9 September Izmir
  12. Post graduated courses / Head and Neck Malignancy Course/24-25 Noyabr 2018 Istanbul
  13. Post graduated courses / Central Nervous System Malignancy and Sarcom’s Course/ 9-10 Feburary 2019 Izmir
  14. Post graduated courses / Urological Malignancy Course/ 4-5 May 2019 Ankara
  15. Course of Supportive Care and Palliation in Cancer Patients/15-16 June Adana
  16. Best of ASCO 2019/ 22 June Istanbul

Proffesional Societies:

Turkish Society of Medical Oncology

ESMO: European Society for Medical Oncology

ASCO: American Society of Clinical Oncology

WhatsApp chat